ArticleIranian journal of basic medical sciences2026
Metformin mitigates oxidative stress and prevents apoptosis by modulating the Nrf2/HO-1 signaling pathway in a rat model of testicular ischemia/reperfusion.
Article in Iranian journal of basic medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dose-dependent protective effects of theophylline on testicular endocrine function in a rat model of ischemia-reperfusion injury.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to investigate the effect of metformin on testicular ischemia-reperfusion (I/R) injury in rats. Materials and Methods: Eighteen male SD rats were randomly divided into three groups: Sham group, I/R group, and Metformin (Met) group (n=6 per group). The I/R model was established by rotating the left testis 720° clockwise and fixing it for 1 hr, followed by reperfusion for 4 hr. Rats in the Met group were intraperitoneally injected with 300 mg/kg metformin for 30 min before reperfusion. In contrast, the Sham group underwent a similar surgical procedure without testicular rotation. Histopathological examination, biochemical assays (MDA and SOD), TUNEL assay for germ cell apoptosis, and Western blot analysis for Nrf2, HO-1, and Keap1 protein expressions were performed. Results: Compared with the Sham group, the I/R group exhibited severe testicular tissue damage, including seminiferous tubule atrophy, disordered spermatogenic epithelium, increased MDA levels, decreased SOD activity, elevated germ cell apoptosis index, up-regulated Nrf2 and HO-1 expressions, and down-regulated Keap1 expression. In contrast, pretreatment with metformin in the Met group significantly ameliorated these pathological changes, as evidenced by improved testicular histology, reduced MDA concentration, increased SOD activity, decreased apoptosis, and reversal of the expression of Nrf2, HO-1, and Keap1 compared with the I/R group. Conclusion: These results indicate that metformin exerts a protective effect against testicular I/R injury, which may be associated with its anti-oxidant, anti-apoptotic properties, and regulation of the Nrf2/ HO-1pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.